The Workup After Recurrent Pregnancy Loss

What Recurrent Pregnancy Loss Means, and Why Testing Helps

Recurrent pregnancy loss means more than one miscarriage, and reaching a workup usually comes after a stretch of grief that most people carry quietly. A recurrent-loss evaluation exists because a minority of couples have a specific, sometimes treatable reason behind the losses — and because for many others, testing that comes back clear is its own kind of answer.

Clinicians differ on exactly how many losses should prompt a full evaluation, and where that line sits — after two miscarriages in a row, or after three — is a real question with its own considerations; some people are offered testing earlier when age or other factors raise the stakes. The recurrent miscarriage how many before testing question is worth settling with a clinician rather than alone. What almost everyone agrees on is that the losses are not the couple's fault, and that a methodical workup beats searching the internet at 2am for a pattern.

One thing worth saying plainly at the start: a workup that finds nothing is common, and it is not the same as a workup that found something wrong. Many couples never identify a single cause. That is frightening in the moment, because it can feel like being sent away empty-handed. It also does not close the door — the absence of a finding is not a verdict.

How a Recurrent-Loss Workup Is Organized

A recurrent-loss workup follows the same discipline as any careful fertility workup: it is systematic and least-invasive-first, moving from history and simple blood tests toward imaging, rather than throwing every test at the problem at once 1Ref 1Practice Committee of ASRM (2021).Fertility evaluation of infertile women: a committee opinion.That a fertility evaluation is systematic and least-invasive-first — moving from history and simple tests to imaging of the uterine cavity and tubes (such as a hysterosalpingogram) — which is the same order-of-operations a recurrent-loss workup follows for its imaging.. The order matters, because the cheapest, safest tests rule things in or out before anyone reaches for the invasive ones.

In practice that means a clinician starts with your history — the pattern and timing of the losses, your cycles, your medical background — and a focused set of blood tests, then adds imaging of the uterus and tubes if it is warranted 1Ref 1Practice Committee of ASRM (2021).Fertility evaluation of infertile women: a committee opinion.That a fertility evaluation is systematic and least-invasive-first — moving from history and simple tests to imaging of the uterine cavity and tubes (such as a hysterosalpingogram) — which is the same order-of-operations a recurrent-loss workup follows for its imaging.. Understanding the fertility workup order of tests helps the whole process feel less random: each step is chosen to answer a specific question, and a step is often skipped if an earlier one already explains the picture.

The tests cluster into four questions. Are the chromosomes — yours, your partner's, or the pregnancy's — part of the story? Is the uterus shaped in a way that makes a pregnancy hard to hold? Is the blood-clotting or immune system involved? And are the hormones that support early pregnancy in range? The sections below take each in turn.

The Chromosome and Uterus Questions

Two of the four questions have concrete, well-established tests. The chromosome question is answered by a parental karyotype — a blood test on each partner that checks whether either carries a balanced rearrangement of their chromosomes, something that can be invisible in the person but cause repeated losses. When it is available, the tissue from a miscarriage can also be tested to see whether that pregnancy carried a chromosomal error.

A balanced translocation is the classic example: the person is healthy because all their genetic material is present, just arranged unusually, but the eggs or sperm they make can carry an unbalanced amount, and those pregnancies often do not continue. Finding it changes the conversation about options, which is why karyotype testing after multiple miscarriages is a standard part of the workup. The dedicated page on parental karyotype recurrent miscarriage covers what the result does and does not mean.

The uterus question is answered with imaging of the uterine cavity and tubes — a saline sonogram, a hysterosalpingogram, or a hysteroscopy — the same imaging a standard female fertility workup uses 1Ref 1Practice Committee of ASRM (2021).Fertility evaluation of infertile women: a committee opinion.That a fertility evaluation is systematic and least-invasive-first — moving from history and simple tests to imaging of the uterine cavity and tubes (such as a hysterosalpingogram) — which is the same order-of-operations a recurrent-loss workup follows for its imaging.. Here it is read for a septum, fibroid, or polyp. A uterine septum is the most relevant of these, because it is both a recognized structural cause of loss and, in selected cases, correctable.

Testing the tissue from a loss, when it can be done, adds a useful piece: if a miscarriage carried a random chromosomal error, that points toward bad luck rather than a persistent problem, which can be genuinely reassuring even though it is not a fix. A normal parental karyotype is common and is good news — it means neither partner is passing on a structural rearrangement — but a normal result does not, on its own, explain the losses, which is why the workup looks in more than one place.

The Clotting and Hormone Questions

The clotting-and-immune question centers on antiphospholipid syndrome, an autoimmune condition in which the body makes antibodies that promote clotting and can interfere with a developing placenta. It is one of the few causes of recurrent loss with a recognized, effective treatment, which is exactly why it earns a place in the workup even though most people who are tested will not have it.

The diagnosis is deliberate: the antibodies must be present and then confirmed on repeat testing weeks later, so a single positive result is not the end of the story. Because antiphospholipid syndrome and miscarriage are a treatable pairing, this is one test where a clear answer genuinely changes the next pregnancy's plan. The page on blood clotting disorder recurrent pregnancy loss walks through what the antibodies are and how a result is confirmed.

The hormone question is broader and mostly answered by blood tests. Thyroid function, prolactin, and blood sugar all affect early pregnancy, and an out-of-range result can sometimes be corrected. These are inexpensive tests, which is why they sit early in the least-invasive-first order. None of them explains most losses, but each is worth ruling out — because a treatable finding, however uncommon, is the whole point of looking.

What About IVF, PGT-A, and Add-Ons?

After recurrent losses, many couples are steered toward IVF with preimplantation genetic testing for aneuploidy (PGT-A), on the logic that screening embryos for chromosomal errors before transfer should prevent the losses. It is an appealing idea, and in specific situations it has a rationale — but the evidence that PGT-A raises the chance of a baby for the general IVF patient has not been demonstrated 2Ref 2Practice Committees of ASRM and SART (2024).The use of preimplantation genetic testing for aneuploidy: a committee opinion.That the value of PGT-A as a routine screen for all IVF patients has not been demonstrated and that recent multicenter RCTs found similar pregnancy outcomes with versus without it — so its marketing can outrun the trial evidence..

A large multicenter randomized trial in good-prognosis patients found that PGT-A did not improve ongoing-pregnancy rates compared with selecting embryos by their appearance 3Ref 3Munné S, et al. (STAR Study Group) (2019).Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial.That in a multicenter randomized trial of good-prognosis patients, PGT-A did not improve ongoing-pregnancy rates compared with selecting embryos by morphology.. PGT-A is an option to discuss for specific reasons — not an automatic answer to recurrent loss. That distinction matters, because the marketing around embryo testing often outruns the trial evidence 2Ref 2Practice Committees of ASRM and SART (2024).The use of preimplantation genetic testing for aneuploidy: a committee opinion.That the value of PGT-A as a routine screen for all IVF patients has not been demonstrated and that recent multicenter RCTs found similar pregnancy outcomes with versus without it — so its marketing can outrun the trial evidence.. The same caution applies to other add-ons: injecting sperm directly into every egg (ICSI), for instance, does not improve live-birth rates when there is no male-factor reason to use it 4Ref 4Practice Committees of ASRM and SART (2026).Intracytoplasmic sperm injection for nonmale factor indications: a committee opinion.That, absent a male-factor or prior fertilization-failure reason, routine ICSI on all oocytes does not improve live-birth rates — an add-on justified by indication rather than a default upgrade..

None of this means IVF or PGT-A is wrong after recurrent loss — for a couple with a known chromosomal rearrangement, testing embryos can be exactly the right tool. It means the decision deserves a clear-eyed conversation about what the testing can and cannot do for your specific situation, rather than being adopted as a default. Asking directly about recurrent pregnancy loss care standards, and getting a second opinion, is reasonable.

It helps to separate what embryo testing can do from what it is being sold to do. PGT-A can identify embryos with the wrong number of chromosomes before transfer, which is a real capability — but identifying them has not translated into more babies for the average patient in the trials, partly because such embryos often fail on their own and partly because the testing itself can occasionally mislabel a viable embryo 2Ref 2Practice Committees of ASRM and SART (2024).The use of preimplantation genetic testing for aneuploidy: a committee opinion.That the value of PGT-A as a routine screen for all IVF patients has not been demonstrated and that recent multicenter RCTs found similar pregnancy outcomes with versus without it — so its marketing can outrun the trial evidence.3Ref 3Munné S, et al. (STAR Study Group) (2019).Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial.That in a multicenter randomized trial of good-prognosis patients, PGT-A did not improve ongoing-pregnancy rates compared with selecting embryos by morphology.. For a couple whose losses trace to a known chromosomal rearrangement, that capability is worth having; for a couple with an unexplained pattern, it is a conversation to have with clear eyes, not a reflex.

What You Can Change, and Where Age Fits

Alongside the tests, a workup usually revisits the modifiable factors that affect pregnancy. Smoking is the clearest: tobacco, nicotine, and cannabis are linked to a higher risk of pregnancy loss, along with reduced conception and lower success with fertility treatment 5Ref 5Practice Committee of ASRM (2024).Tobacco or marijuana use and infertility: a committee opinion.That tobacco, nicotine, and marijuana are linked to a higher risk of pregnancy loss, along with reduced conception and lower success with fertility treatment.. Stopping is one of the few levers a couple can actually pull, and it is worth doing regardless of what the rest of the workup finds.

Age belongs in the picture too, though gently. Fecundity declines gradually from about age 32 and more rapidly after 37 6Ref 6American College of Obstetricians and Gynecologists (2025).Anticipatory Counseling Regarding Ovarian-Factor Fertility Decline (Committee Statement No. 22).That fecundity declines gradually from about age 32 and more rapidly after age 37, offered here as age context for a couple weighing timing after loss., and what changes with age is egg quality as much as quantity. That is context rather than a cause to fix — it helps a couple weigh options and timing, including how long to wait before trying again. The question of conceiving after loss — when it is reasonable to try again — is common and worth asking directly, because the answer is often sooner than people fear.

The honest summary is that the modifiable list is short and age is not on it. What a workup can change is knowledge: which of the treatable causes are present, which are ruled out, and what that means for the next pregnancy. That is a smaller promise than 'here is why this happened,' but it is a real one.

Finding Care That Takes Recurrent Loss Seriously

Not every clinic approaches recurrent loss the same way, and the workup above is a reasonable benchmark to hold a consultation against. A thorough evaluation is methodical, explains why each test is being ordered, and is honest about the odds that it will find nothing — rather than reaching immediately for the most expensive intervention.

Good recurrent-loss clinic vetting means asking whether the standard tests — parental karyotype, antiphospholipid antibodies, uterine cavity imaging, and the basic hormone panel — are part of the plan, and how a clinic interprets a normal result. A clinician who treats an unexplained workup as a dead end, or who pushes straight to add-ons without a specific reason, is worth a second opinion. The measure of good care here is not how many tests are run, but how clearly each one is justified and how honestly its limits are named.

Recurrent loss is one of the few fertility situations where the emotional weight and the medical uncertainty are both high at once. A workup will not always deliver a reason, but it can replace the 2am search for a pattern with a structured set of answers — some of them treatable, most of them at least ruled out. That is what the evaluation is for.

It is also reasonable to bring a partner, a written list of the losses and their timing, and any prior test results to that first consultation — the more complete the history, the more targeted the workup, and the fewer tests that get repeated needlessly. Recurrent loss is a place where being an organized advocate for your own care genuinely changes what the evaluation can do.